Physician profile

Jonathan J Richards

Podiatrist · Englewood, NJ

NPI 1649594193

$79,187.42

in general payments reported to CMS, 2019-2025

34 companies · $61K in 2025

The $61K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$38,526.88
Food and Beverage$17,858.16
Travel and Lodging$9,522.80
Education$4,041.25
Consulting Fee$1,525.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kerecis Limited $53,455.87 2023-2025 Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen
Stryker Corporation $12,919.75 2019-2025 Prostep, Citrefix, Prostep Mica
Zimmer Biomet Holdings, INC. $2,688.91 2020-2023 Dvr Anatomic Kickstand
Treace Medical Concepts, INC. $1,479.16 2023-2025
Trilliant Surgical LLC. $905.07 2025 Arsenal Sinus Support Plate, Arsenal Ankle
Royal Biologics, INC. $809.63 2021-2022
Medtronic, INC. $758.11 2023-2025 Intellis Adaptivestim, Inceptiv
Amniox Medical, INC. $751.62 2019
Novastep INC. $466.93 2022-2025 Nexis
Smith+Nephew, INC. $458.19 2019-2025 Renasys Touch, Pico, Collagenase Santyl
Paragon 28, INC. $452.35 2024-2025 Grappler, Phantom Fibula Nail, Portfolio
Medshape, INC. $435.54 2023-2025 Dynanail Helix, Washer, 15 Mm, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm
Integra Lifesciences Corporation $416.51 2023-2024 Integra, Integra Dermal Regeneration Template, Primatrix
Extremity Medical $405.90 2024
Acera Surgical, INC. $304.23 2024 Restrata Wound Matrix
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Wright Medical Technology, INC. $297.08 2019
Horizon Therapeutics Plc $264.65 2019-2022
Organogenesis INC. $243.98 2022-2023 Puraply Antimicrobial, Puraply
Kowa Pharmaceuticals America, INC. $231.59 2022-2023 Seglentis
Musculoskeletal Transplant Foundation INC. $190.31 2021-2025
Melinta Therapeutics, LLC $175.29 2019
Arteriocyte Medical Systems, INC. $172.53 2025 Magellan
Pfizer INC. $166.40 2019-2020
Ortho Dermatologics, A Division of Bausch Health US, LLC $146.45 2020
Amgen INC. $143.86 2024 Krystexxa
Abbott Laboratories $141.54 2024 Proclaim
Averitas Pharma INC. $89.93 2024 Qutenza
Nevro Corp. $83.69 2022
Orthofix Medical, INC. $35.97 2019-2024 Physio-Stim
Boston Scientific Corporation $26.37 2019
Curonix LLC $21.03 2024 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Paratek Pharmaceuticals, INC. $20.51 2025 Nuzyra
Bioventus LLC $14.61 2019
Dynasplint Systems INC. $13.86 2025 Dynasplint

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jonathan J Richards

$79,187.42

in general payments reported 2019-2025

Years
2019-2025
Top company
Kerecis Limited
Context
The $61K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).

https://glasscript.com/doctor/346930/jonathan-j-richards

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.